search
Back to results

Task Sharing for the Care of Severe Mental Disorders in a Low-income Country (TaSCS)

Primary Purpose

Schizophrenia, Bipolar Disorder, Major Depressive Disorder

Status
Completed
Phase
Phase 3
Locations
Ethiopia
Study Type
Interventional
Intervention
Integrated mental health in primary care
Psychiatric nurse-led specialist care
Sponsored by
University of Cape Town
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Schizophrenia focused on measuring task sharing, task shifting, community mental health care, primary care, Developing country, Sub-Saharan Africa, non-inferiority trial

Eligibility Criteria

25 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria for phase 1

  • Participant in the ongoing Butajira SMD cohort study (at baseline (between 1998 and 2001), cohort participants were aged between 15 and 49 years, resident in the area for at least six months and had a DSM-IV (SCAN) diagnosis of schizophrenia or schizoaffective disorder, bipolar disorder or major depressive disorder)
  • Ongoing need for continuing mental health care due to:

    1. being on psychotropic medication at assessment or,
    2. not on medication but symptomatic at the time of assessment, or
    3. have experienced partial or full relapse within the two years preceding the assessment
  • Stable clinical condition: either in remission from SMD or with residual symptoms that have been stable over the preceding three months.
  • Planning to stay resident in the area for 18 months.
  • Able to communicate in Amharic, the official language of Ethiopia.
  • Willing to be randomised to either of the service models as described in the protocol.
  • Has capacity to consent to participation or permission given by guardian and not refusing to participate
  • Resident in catchment area of TaSCS health centres (excluding Butajira health centre)

Exclusion criteria for phase 1

  • Suicide attempt within the preceding three months
  • Current active suicide intent
  • Prescribed Thioridazine, Valproate, Lithium or second generation antipsychotic medications (Risperidone and Olanzapine), as these medications are not be available in psychiatric nurse-led units or PHC settings in Ethiopia. Within the Butajira SMD cohort, only people who have received care from psychiatrist-led units in the capital city, Addis Ababa, might be receiving these medications. At present, fewer than 10 patients are known to be taking one of these medications.
  • Prescribed depot medication
  • Complex or unstable medical condition interfering with management of psychiatric disorder or requiring ongoing medical treatment from Butajira hospital
  • Alcohol or khat dependence or abuse within the last 12 months
  • Pregnant or breast-feeding
  • Restrained at home
  • Refusing to participate in the study

Inclusion criteria for Phase 2 As for Phase 1, but if we are unable to recruit enough participants from the existing Butajira SMD cohort then we will expand recruitment to people with SMD attending the psychiatric out-patient clinic at Butajira hospital. A semi-structured diagnostic interview will be carried out to determine diagnostic eligibility (DSM-IV diagnosis of schizophrenia or schizoaffective disorder, bipolar disorder or major depressive disorder). For participants recruited from Butajira hospital psychiatric out-patient clinic, the minimum age will be 25 years and the participants should have had their first contact with specialist mental health services at least two years prior to recruitment into the trial to ensure comparability with the Butajira SMD cohort sample.

Exclusion criteria for Phase 2

  • Current active suicide intent
  • Prescribed Thioridazine, Valproate, Lithium or second generation antipsychotic medications (Risperidone and Olanzapine).
  • Pregnant or breast-feeding and prescribed depot
  • Refusing to participate in the study
  • Medical condition requiring ongoing medical treatment from Butajira hospital

Sites / Locations

  • Butajira mental health research office

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Integrated mental health in primary care

Psychiatric nurse-led specialist care

Arm Description

Participants in the new intervention arm will receive a task sharing model of locally-delivered mental health care integrated into primary healthcare. General health workers (health officers, nurses and community-based health extension workers) will be given brief training using the WHO's mental health Gap Action Programme and ongoing supervision in order to deliver mental health care to people with severe mental disorders.

Participants in the active control arm will receive an established model of centralised, specialist mental health care delivered by psychiatric nurses at an out-patient clinic within Butajira general hospital and supported by outreach from project workers.

Outcomes

Primary Outcome Measures

Brief Psychiatric Rating Scale, Expanded Version (BPRS-E)
Symptom severity scale. Non-inferiority of the experimental intervention is defined as less than six point difference in BPRS-E score between the two arms.

Secondary Outcome Measures

WHO Disability Assessment Scale, version 2.0 (WHODAS 2.0)
Generic disability scale.
Local functioning scale (disability scale for people with severe mental disorders developed specifically for this trial)
Contextually appropriate l.
Relapse of mental disorder (Measured using the Life Chart Schedule)
Measured using the Life Chart Schedule
Patient service satisfaction (Newly developed 'mental health service satisfaction scale' and qualitative interviews.)
Newly developed 'mental health service satisfaction scale' and qualitative interviews.
Nutritional status (Body mass index.)
Body mass index.
Service use for physical health care (Client Service Receipt Inventory)
Captured through reimbursement mechanisms and the Client Service Receipt Inventory
Medication side effects (Antipsychotic Side effect Checklist)
Measured using the Antipsychotic Side effect Checklist
Patient adherence and engagement (Medication Adherence Measure and tracking of appointment attendance.)
Medication Adherence Measure and tracking of appointment attendance.
Stigma (Family Interview Schedule (caregivers)
Internalised stigma of mental illness (patients) and the Family Interview Schedule (caregivers)
Restraint (Proportion chained, restrained of confined in the past month.)
Proportion chained, restrained of confined in the past month.
Adverse event
Life Chart Schedule and tracking of serious adverse events.
Quality of clinical care (WHO's mental health gap intervention guide)
Systematic evaluation of quality of documented care compared to evidence-based recommendations in WHO's mental health gap intervention guide.
Acceptability and feasibility (in-depth interviews with patients, caregivers and health care providers.)
Qualitative study using in-depth interviews with patients, caregivers and health care providers.

Full Information

First Posted
December 3, 2014
Last Updated
November 28, 2017
Sponsor
University of Cape Town
Collaborators
Addis Ababa University, King's College London, Johns Hopkins University, Columbia University, Armauer Hansen Research Institute, Ethiopia
search

1. Study Identification

Unique Protocol Identification Number
NCT02308956
Brief Title
Task Sharing for the Care of Severe Mental Disorders in a Low-income Country
Acronym
TaSCS
Official Title
Task Sharing for the Care of Severe Mental Disorders in a Low-income Country: a Randomised, Controlled Non-inferiority Trial
Study Type
Interventional

2. Study Status

Record Verification Date
November 2017
Overall Recruitment Status
Completed
Study Start Date
March 2015 (undefined)
Primary Completion Date
May 16, 2017 (Actual)
Study Completion Date
November 16, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Cape Town
Collaborators
Addis Ababa University, King's College London, Johns Hopkins University, Columbia University, Armauer Hansen Research Institute, Ethiopia

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Task sharing mental health care through integration of mental health into primary health care (PHC) is advocated as a means of narrowing the treatment gap for mental disorders in low-income countries. In Ethiopia, it is estimated that only around 10% of people with severe mental disorders (SMDs) ever receive evidence-based treatment for their condition, largely due to scarcity of specialist mental health services. A task-sharing model of mental health care in PHC would be more affordable and accessible to the majority of persons with SMD who do not currently receive evidence-based mental health care. Furthermore, task sharing mental health care with PHC is about to be scaled up in Ethiopia in line with the National Mental Health Strategy. However, the effectiveness of the task sharing model of mental health care for people with SMD has not been evaluated systematically in a low-income country. In this study we propose to investigate non-inferiority of a task sharing model of mental health care in PHC compared to a less accessible, but more specialist, psychiatric nurse-led model of care. The specialist model of care has been demonstrated to be acceptable and associated with improved clinical outcomes for persons with SMD engaged in the service in Ethiopia thus making this an appropriate comparison model against which to evaluate non-inferiority of the task sharing model.
Detailed Description
Background and rationale Task sharing mental health care through integration of mental health into primary health care (PHC) is advocated as a means of narrowing the treatment gap for mental disorders in low-income countries. In Ethiopia, it is estimated that only around 10% of people with severe mental disorders (SMDs) ever receive evidence-based treatment for their condition, largely due to scarcity of specialist mental health services. A task-sharing model of mental health care in PHC would be more affordable and accessible to the majority of persons with SMD who do not currently receive evidence-based mental health care. Furthermore, task sharing mental health care with PHC is about to be scaled up in Ethiopia in line with the National Mental Health Strategy. However, the effectiveness of the task sharing model of mental health care for people with SMD has not been evaluated systematically in a low-income country. In this study we propose to investigate non-inferiority of a task sharing model of mental health care in PHC compared to a less accessible, but more specialist, psychiatric nurse-led model of care. The specialist model of care has been demonstrated to be acceptable and associated with improved clinical outcomes for persons with SMD engaged in the service in Ethiopia thus making this an appropriate comparison model against which to evaluate non-inferiority of the task sharing model. Methods Setting Meskan and Mareko districts, Gurage Zone, and Silti Zone, Southern Nations, Nationalities and People's Region, Ethiopia. Design A parallel group, randomized, single-blinded, controlled non-inferiority trial. Participants Adults (aged between 25 and 65 years) with severe mental disorders (DSM-IV diagnoses of schizophrenia or schizoaffective disorder, bipolar disorder or major depressive disorder) of a severity requiring continuing care who were (1) identified during a population-based survey carried out between 1998 and 2001, and are still under active follow-up, or (2) recruited from Butajira hospital psychiatric outpatient clinic. Participants will be recruited and randomised in two phases. Phase 1 will include participants who are clinically stable, not pregnant or breastfeeding, not on depot medication and who have no co-morbid substance use or complex medical conditions. After a three month evaluation period, and if no safety or quality issues arise, the study will proceed to Phase 2. Phase 2 will include participants who have more complex needs or are less clinically stable. New intervention Participants in the new intervention arm will receive a task sharing model of locally-delivered mental health care integrated into PHC. The intervention will be offered for 18 months. Comparison intervention Participants in the active control arm will receive the established model of specialist mental health care delivered by psychiatric nurses at an out-patient clinic within Butajira general hospital and supported by outreach from project workers. General objective To determine the acceptability, affordability, effectiveness and sustainability of mental health care for persons with SMD delivered by trained and supervised non-specialist, primary health care workers compared with an existing psychiatric nurse-led service. Specific objectives For persons suffering from SMD in Butajira, Ethiopia, To determine the effectiveness and cost-effectiveness of task sharing mental health care with PHC, compared to psychiatric nurse-led mental health care, on the primary outcome measure of symptom severity and on a series of secondary outcome measures. To examine factors influencing the implementation of the task sharing intervention and future scale up, by examining feasibility, sustainability, quality, and safety, and by qualitative exploration of the experience of task sharing from the perspectives of both PHC workers and patients. Hypothesis Persons with SMD who receive mental health care task-shared with PHC will have a non-inferior clinical outcome, defined as a difference in the mean symptom score on the Brief Psychiatric Rating Scale, expanded version (BPRS-E), of no more than six points higher, compared to persons with SMD who receive a psychiatric nurse-led model of mental health care, after 12 months of care under the comparison service models. Sample size A total of 324 participants (162 in each arm) will be required to detect a six point higher mean BPRS-E score in the new intervention arm compared to the active control arm, at 90% power and 95% confidence, allowing for 30% refusals and loss to follow-up (n = 124 for Phase 1 and n = 200 for Phase 2). Randomisation Sequence generation: Computerized generation of randomization list. Blocked randomization stratified by health centre catchment area. Allocation concealment: Labelled, sealed envelopes containing cards with intervention allocation administered by an independent clinician. Implementation: Enrollment will occur after participants have been screened for eligibility, given informed consent (or permission given by guardian) and undergone baseline evaluation. After enrollment, an independent clinician will inform the participant of their allocation status. Concealment Partial concealment. Outcome assessment and data analysis will be carried out by investigators who are masked to the intervention allocation of participants. Statistical methods Intention to treat will be the primary approach to data analysis, but per protocol analyses will also be used as this is thought to more conservative in the case of non-inferiority trials. The primary outcome measure will be analysed using linear regression adjusting for baseline symptom severity measured using BPRS-E.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Schizophrenia, Bipolar Disorder, Major Depressive Disorder, Schizoaffective Disorder
Keywords
task sharing, task shifting, community mental health care, primary care, Developing country, Sub-Saharan Africa, non-inferiority trial

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
324 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Integrated mental health in primary care
Arm Type
Experimental
Arm Description
Participants in the new intervention arm will receive a task sharing model of locally-delivered mental health care integrated into primary healthcare. General health workers (health officers, nurses and community-based health extension workers) will be given brief training using the WHO's mental health Gap Action Programme and ongoing supervision in order to deliver mental health care to people with severe mental disorders.
Arm Title
Psychiatric nurse-led specialist care
Arm Type
Active Comparator
Arm Description
Participants in the active control arm will receive an established model of centralised, specialist mental health care delivered by psychiatric nurses at an out-patient clinic within Butajira general hospital and supported by outreach from project workers.
Intervention Type
Behavioral
Intervention Name(s)
Integrated mental health in primary care
Intervention Description
A task-shared model of collaborative mental health care integrated into the primary care setting.
Intervention Type
Behavioral
Intervention Name(s)
Psychiatric nurse-led specialist care
Intervention Description
A centralised, psychiatric nurse-led, hospital out-patient service with outreach from project outreach workers
Primary Outcome Measure Information:
Title
Brief Psychiatric Rating Scale, Expanded Version (BPRS-E)
Description
Symptom severity scale. Non-inferiority of the experimental intervention is defined as less than six point difference in BPRS-E score between the two arms.
Time Frame
12 months post-randomisation (18 months for secondary outcome)
Secondary Outcome Measure Information:
Title
WHO Disability Assessment Scale, version 2.0 (WHODAS 2.0)
Description
Generic disability scale.
Time Frame
12 and 18 months post-randomisation
Title
Local functioning scale (disability scale for people with severe mental disorders developed specifically for this trial)
Description
Contextually appropriate l.
Time Frame
12 and 18 months post-randomisation
Title
Relapse of mental disorder (Measured using the Life Chart Schedule)
Description
Measured using the Life Chart Schedule
Time Frame
12 and 18 months post-randomisation
Title
Patient service satisfaction (Newly developed 'mental health service satisfaction scale' and qualitative interviews.)
Description
Newly developed 'mental health service satisfaction scale' and qualitative interviews.
Time Frame
12 and 18 months post-randomisation
Title
Nutritional status (Body mass index.)
Description
Body mass index.
Time Frame
12 and 18 months post-randomisation
Title
Service use for physical health care (Client Service Receipt Inventory)
Description
Captured through reimbursement mechanisms and the Client Service Receipt Inventory
Time Frame
12 and 18 months post-randomisation
Title
Medication side effects (Antipsychotic Side effect Checklist)
Description
Measured using the Antipsychotic Side effect Checklist
Time Frame
12 and 18 months post-randomisation
Title
Patient adherence and engagement (Medication Adherence Measure and tracking of appointment attendance.)
Description
Medication Adherence Measure and tracking of appointment attendance.
Time Frame
12 and 18 months post-randomisation
Title
Stigma (Family Interview Schedule (caregivers)
Description
Internalised stigma of mental illness (patients) and the Family Interview Schedule (caregivers)
Time Frame
12 and 18 months post-randomisation
Title
Restraint (Proportion chained, restrained of confined in the past month.)
Description
Proportion chained, restrained of confined in the past month.
Time Frame
12 and 18 months post-randomisation
Title
Adverse event
Description
Life Chart Schedule and tracking of serious adverse events.
Time Frame
12 and 18 months post-randomisation
Title
Quality of clinical care (WHO's mental health gap intervention guide)
Description
Systematic evaluation of quality of documented care compared to evidence-based recommendations in WHO's mental health gap intervention guide.
Time Frame
12 and 18 months post-randomisation
Title
Acceptability and feasibility (in-depth interviews with patients, caregivers and health care providers.)
Description
Qualitative study using in-depth interviews with patients, caregivers and health care providers.
Time Frame
6 months post-randomisation onwards

10. Eligibility

Sex
All
Minimum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria for phase 1 Participant in the ongoing Butajira SMD cohort study (at baseline (between 1998 and 2001), cohort participants were aged between 15 and 49 years, resident in the area for at least six months and had a DSM-IV (SCAN) diagnosis of schizophrenia or schizoaffective disorder, bipolar disorder or major depressive disorder) Ongoing need for continuing mental health care due to: being on psychotropic medication at assessment or, not on medication but symptomatic at the time of assessment, or have experienced partial or full relapse within the two years preceding the assessment Stable clinical condition: either in remission from SMD or with residual symptoms that have been stable over the preceding three months. Planning to stay resident in the area for 18 months. Able to communicate in Amharic, the official language of Ethiopia. Willing to be randomised to either of the service models as described in the protocol. Has capacity to consent to participation or permission given by guardian and not refusing to participate Resident in catchment area of TaSCS health centres (excluding Butajira health centre) Exclusion criteria for phase 1 Suicide attempt within the preceding three months Current active suicide intent Prescribed Thioridazine, Valproate, Lithium or second generation antipsychotic medications (Risperidone and Olanzapine), as these medications are not be available in psychiatric nurse-led units or PHC settings in Ethiopia. Within the Butajira SMD cohort, only people who have received care from psychiatrist-led units in the capital city, Addis Ababa, might be receiving these medications. At present, fewer than 10 patients are known to be taking one of these medications. Prescribed depot medication Complex or unstable medical condition interfering with management of psychiatric disorder or requiring ongoing medical treatment from Butajira hospital Alcohol or khat dependence or abuse within the last 12 months Pregnant or breast-feeding Restrained at home Refusing to participate in the study Inclusion criteria for Phase 2 As for Phase 1, but if we are unable to recruit enough participants from the existing Butajira SMD cohort then we will expand recruitment to people with SMD attending the psychiatric out-patient clinic at Butajira hospital. A semi-structured diagnostic interview will be carried out to determine diagnostic eligibility (DSM-IV diagnosis of schizophrenia or schizoaffective disorder, bipolar disorder or major depressive disorder). For participants recruited from Butajira hospital psychiatric out-patient clinic, the minimum age will be 25 years and the participants should have had their first contact with specialist mental health services at least two years prior to recruitment into the trial to ensure comparability with the Butajira SMD cohort sample. Exclusion criteria for Phase 2 Current active suicide intent Prescribed Thioridazine, Valproate, Lithium or second generation antipsychotic medications (Risperidone and Olanzapine). Pregnant or breast-feeding and prescribed depot Refusing to participate in the study Medical condition requiring ongoing medical treatment from Butajira hospital
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Charlotte Hanlon, BM BS, PhD
Organizational Affiliation
Addis Ababa University and King's College London
Official's Role
Principal Investigator
Facility Information:
Facility Name
Butajira mental health research office
City
Butajira
Country
Ethiopia

12. IPD Sharing Statement

Citations:
PubMed Identifier
18448478
Citation
Alem A, Kebede D, Fekadu A, Shibre T, Fekadu D, Beyero T, Medhin G, Negash A, Kullgren G. Clinical course and outcome of schizophrenia in a predominantly treatment-naive cohort in rural Ethiopia. Schizophr Bull. 2009 May;35(3):646-54. doi: 10.1093/schbul/sbn029. Epub 2008 Apr 29.
Results Reference
background
Citation
Federal Democratic Republic of Ethiopia Ministry of Health (2012). National Mental Health Strategy, 2012/13-2015/16. Addis Ababa, Ministry of Health.
Results Reference
background
PubMed Identifier
26290926
Citation
mhGAP: Mental Health Gap Action Programme: Scaling Up Care for Mental, Neurological and Substance Use Disorders. Geneva: World Health Organization; 2008. Available from http://www.ncbi.nlm.nih.gov/books/NBK310851/
Results Reference
background
Citation
Overall, J. and D. Gorham (1962). The Brief Psychiatric Rating Scale. Psychological Reports 10: 799-812.
Results Reference
background
PubMed Identifier
34921796
Citation
Hanlon C, Medhin G, Dewey ME, Prince M, Assefa E, Shibre T, Ejigu DA, Negussie H, Timothewos S, Schneider M, Thornicroft G, Wissow L, Susser E, Lund C, Fekadu A, Alem A. Efficacy and cost-effectiveness of task-shared care for people with severe mental disorders in Ethiopia (TaSCS): a single-blind, randomised, controlled, phase 3 non-inferiority trial. Lancet Psychiatry. 2022 Jan;9(1):59-71. doi: 10.1016/S2215-0366(21)00384-9.
Results Reference
derived
PubMed Identifier
26865254
Citation
Hanlon C, Alem A, Medhin G, Shibre T, Ejigu DA, Negussie H, Dewey M, Wissow L, Prince M, Susser E, Lund C, Fekadu A. Task sharing for the care of severe mental disorders in a low-income country (TaSCS): study protocol for a randomised, controlled, non-inferiority trial. Trials. 2016 Feb 11;17:76. doi: 10.1186/s13063-016-1191-x. Erratum In: Trials. 2020 Oct 6;21(1):829.
Results Reference
derived

Learn more about this trial

Task Sharing for the Care of Severe Mental Disorders in a Low-income Country

We'll reach out to this number within 24 hrs